| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 699490 | Doxoform | 0.0268790882218883 | -0.10987301 |
| NSC 744989 | 7-methoxy-8-[(5-2-methoxy-4-[(E)-3-(2,4-dimethyl-3-quinolyl)-3-oxo-1-propenyl]phenoxybutyl)oxy]-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one | 0.0268790882218883 | -0.036886128 |
| NSC 44684 | Null | 0.0285477013888567 | -0.092544618 |
| NSC 674182 | Null | 0.0285477013888567 | -0.010223396 |
| NSC 679006 | 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester | 0.0285477013888567 | -0.0038398666 |
| NSC 697504 | Null | 0.0285477013888567 | -0.019476495 |
| NSC 736624 | Indenoisoquinoline derivative | 0.0285477013888567 | -0.1095465 |
| NSC 759878 | Irinotecan hydrochloride (USAN) | 0.0285477013888569 | -0.073192989 |
| NSC 658396 | N-(3-Aziridinylpropyl)-1,4-diaminobutane | 0.0285477013888571 | 0.42617976 |
| NSC 669146 | 6,9-Epoxy-2H-1,4-dioxacyclodeca[cd]pentalene-2,7(4aH)-dione, 2a,3,5,6,11a,11b-hexahydro-3-hydroxy-2a,6,10-trimethyl-3-(1-methylethenyl)-, [2aS-(2aR*,3S*,4aR*,6S*,10Z,11aS*,11bS*)]- | 0.0285477013888571 | -0.08939836 |